Therefore, this study provides further rationale and validity for using glucagon as a treatment for hypoglycemia, which is likely to be effective in settings following prolonged fasts such as nocturnal hypoglycemia, individuals with T1D undertaking intermittent fasting, or exercising in the fasted state. The gene discussed is GCG; the disease is Hypoglycemia.